Company intelligence / Profile preview

If and Only If Technologies

Davis, California, United Statesiff.bio ↗

Ownership: Private
Development stage: Other

Overview

If and Only If Technologies ("Iff Technologies") develops computational platforms that enable biological researchers to design drugs and other biomaterials more efficiently. Their flagship product, Polar+, uses advanced protein analysis algorithms—including "protein pruning"—to identify optimal binding sites at the atomic level, supporting drug discovery, protein engineering, and related life science applications. The company operates as a B2B provider of bioinformatics solutions rather than a direct developer of therapeutics or diagnostics.

Industry: Drug Discovery Services

Beyond the preview

Go deeper on If and Only If Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on If and Only If Technologies.

Explore the full profile